“…More than 30 gene polymorphisms in RAGE have been identified in multiple cancers, including renal caner, oral cancer, breast cancer, colorectal cancer, lung cancer, ovarian cancer, pancreatic cancer, nasopharyngeal carcinoma, and gastric cancer (Cheng et al, 2005; Chocholaty et al, 2014; Gu et al, 2008; Krechler et al, 2010; Pan et al, 2013; Qian, Sun, Zhang, Ke, & Zhu, 2014; Su, Chien, Lin, Chen, & Yang, 2015; Zhang et al, 2013; Zhou, Deng, Li, Yin, & Ye, 2014). A comprehensive meta-analysis suggested that the 82G/S polymorphism (3374 cancer cases vs. 3757 controls) in the RAGE promoter region is associated with a significantly increased risk of cancer, where −374T/A polymorphism (2936 cancer cases vs. 3,338 control) is associated with a reduced risk of cancer (Xia et al, 2015).…”